Financial Analysis: Aspyra (OTCMKTS:APYI) vs. Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA) and Aspyra (OTCMKTS:APYI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, profitability and risk.

Institutional & Insider Ownership

94.5% of Privia Health Group shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by insiders. Comparatively, 23.9% of Aspyra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Aspyra has a beta of 2.14, indicating that its share price is 114% more volatile than the S&P 500.

Earnings & Valuation

This table compares Privia Health Group and Aspyra”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$1.74 billion	1.56	$14.39 million	$0.13	169.31
Aspyra	N/A	N/A	N/A	N/A	N/A

Privia Health Group has higher revenue and earnings than Aspyra.

Analyst Ratings

This is a summary of recent recommendations and price targets for Privia Health Group and Aspyra, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0	3	13	0	2.81
Aspyra	0	0	0	0	0.00

Privia Health Group presently has a consensus price target of $30.50, indicating a potential upside of 38.57%. Given Privia Health Group’s stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Aspyra.

Profitability

This table compares Privia Health Group and Aspyra’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.89%	2.52%	1.47%
Aspyra	N/A	N/A	N/A

Summary

Privia Health Group beats Aspyra on 8 of the 10 factors compared between the two stocks.

About Privia Health Group

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.